Forbes August 8, 2024
Bruce Japsen

A big California health insurer that grabbed headlines a year ago for its effort to “rip up the playbook on drug pricing,” may launch with Mark Cuban’s Cost Plus Drugs in a different role than originally billed.

The role of Mark Cuban Cost Plus Drug Company has changed a year after Blue Shield of California a year ago announced the prescription management model that also includes Amazon, a pharmacy benefit venture owned by Blue Cross and Blue Shield plans called Prime Therapeutics, and Abarca Health, a pharmacy benefit and services firm.

A year ago, Blue Shield of California said Mark Cuban Cost Plus Drug Company will “establish a simple, transparent, and more affordable pricing model, reducing surprise drug costs at...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Centene expands board with former Prudential finance chief
Revenue Cycle and Payer News – February 26, 2025
Humana Taps Thyme Care for Value-Based Oncology Care
Trump's new price transparency executive order: 6 notes for payers
Most doctors fear insurers using AI to deny coverage

Share This Article